BIO-key International Files 8-K on Financials
Ticker: BKYI · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1019034
Sentiment: neutral
Topics: financial-condition, results-of-operations
Related Tickers: BKYI
TL;DR
BIO-key International dropped an 8-K detailing its financial condition as of April 1st.
AI Summary
BIO-key International, Inc. filed an 8-K on April 2, 2024, reporting on its results of operations and financial condition as of April 1, 2024. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on BIO-key International's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- BIO KEY INTERNATIONAL INC (company) — Filer
- 101 CRAWFORDS CORNER RD (address) — Business Address
- HOLMDEL (location) — City
- NJ (location) — State
- 7323591100 (phone_number) — Business Phone
- SAC TECHNOLOGIES INC (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on BIO-key International, Inc.'s Results of Operations and Financial Condition as of April 1, 2024.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on April 2, 2024.
What is BIO-key International, Inc.'s principal executive office address?
BIO-key International, Inc.'s principal executive office is located at 101 Crawfords Corner Road, Suite 4116, Holmdel, NJ 07733.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 41-1741861.
What was BIO-key International, Inc.'s former company name?
BIO-key International, Inc.'s former company name was SAC TECHNOLOGIES INC.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-04-02 08:30:48
Filing Documents
- bkyi20240401_8k.htm (8-K) — 26KB
- ex_648746.htm (EX-99.1) — 21KB
- pic1.jpg (GRAPHIC) — 6KB
- 0001437749-24-010505.txt ( ) — 192KB
- bkyi-20240401.xsd (EX-101.SCH) — 3KB
- bkyi-20240401_def.xml (EX-101.DEF) — 11KB
- bkyi-20240401_lab.xml (EX-101.LAB) — 15KB
- bkyi-20240401_pre.xml (EX-101.PRE) — 11KB
- bkyi20240401_8k_htm.xml (XML) — 3KB
02
Item 2.02. Results of Operations and Financial Condition. On April 1, 2024 BIO-key International, Inc. (the "Company") issued a press release announcing its financial results for its fourth quarter and year ended December 31, 2023. A copy of the press release issued by the Company on April 1, 2024 is attached as Exhibit 99. The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
Financial Statements, Pro Forma Financial Information and Exhibit
Financial Statements, Pro Forma Financial Information and Exhibit. (d) Exhibits. The following exhibit is furnished herewith: 99.1 Press Release, dated April 1, 2024 issued by the Company. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-KEY INTERNATIONAL, INC. Date: April 2, 2024 By: /s/ Cecilia C. Welch Cecilia C. Welch Chief Financial Officer EXHIBIT INDEX Exhibit No. Description 99.1 Press Release, dated April 1, 2024 issued by the Company.